Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kyle McElyea"'
Autor:
Maria B. Padua, Poornima Bhat-Nakshatri, Manjushree Anjanappa, Mayuri S. Prasad, Yangyang Hao, Xi Rao, Sheng Liu, Jun Wan, Yunlong Liu, Kyle McElyea, Max Jacobsen, George Sandusky, Sandra Althouse, Susan Perkins, Harikrishna Nakshatri
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-18 (2018)
Abstract Background The majority of estrogen receptor-positive (ERα+) breast cancers respond to endocrine therapies. However, resistance to endocrine therapies is common in 30% of cases, which may be due to altered ERα signaling and/or enhanced pla
Externí odkaz:
https://doaj.org/article/6004230c8bc3416caaf80c8075bbf814
Autor:
Harikrishna Nakshatri, Teresa Zimmers, Jianguo Liu, Peter A Crooks, Narsimha Penthala, George Sandusky, Rachael Redmond, Kyle McElyea, Victoria Sefcsik, Courtney Finnearty, Max Jacobson, Manjushree Anjanappa, Mayuri S Prasad, Maria B. Padua, Poornima Bhat-Nakshatri, Ruizhong Wang
Breast cancer progression is associated with systemic effects, including functional limitations and sarcopenia without the appearance of overt cachexia. Autocrine/paracrine actions of cytokines/chemokines produced by cancer cells mediate cancer progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f44a00990630f5b7333b0d900159592b
https://doi.org/10.1158/1535-7163.c.6539290.v1
https://doi.org/10.1158/1535-7163.c.6539290.v1
Autor:
Harikrishna Nakshatri, Teresa Zimmers, Jianguo Liu, Peter A Crooks, Narsimha Penthala, George Sandusky, Rachael Redmond, Kyle McElyea, Victoria Sefcsik, Courtney Finnearty, Max Jacobson, Manjushree Anjanappa, Mayuri S Prasad, Maria B. Padua, Poornima Bhat-Nakshatri, Ruizhong Wang
The effect of mammary tumor growth in PyMT+ mice on cardiac parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05c28fca5cbc16bb63ce9ff3070aa5f4
https://doi.org/10.1158/1535-7163.22509427
https://doi.org/10.1158/1535-7163.22509427
Autor:
Harikrishna Nakshatri, Teresa Zimmers, Jianguo Liu, Peter A Crooks, Narsimha Penthala, George Sandusky, Rachael Redmond, Kyle McElyea, Victoria Sefcsik, Courtney Finnearty, Max Jacobson, Manjushree Anjanappa, Mayuri S Prasad, Maria B. Padua, Poornima Bhat-Nakshatri, Ruizhong Wang
Tumor incidence and growth patterns in PyMT+ mice with and without DMAPT treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7401a1999747aee72e40aed49aef6354
https://doi.org/10.1158/1535-7163.22509424.v1
https://doi.org/10.1158/1535-7163.22509424.v1
Autor:
Daniel M. Geynisman, Richard E. Greenberg, Elizabeth R. Plimack, Gregory J. Tsongalis, Torrey Gallagher, Francine B. De Abreu, Scott A. Turner, Angela Reed, Rhoda L. Loman, Marietta L. Moore, Costantine Albany, Ziyue Liu, Timothy Breen, George E. Sandusky, Kyle McElyea, David R. Jones, Liang Cheng, Thomas A. Gardner, Richard S. Foster, Richard Bihrle, Michael O. Koch, Timothy A. Masterson, Carolyn Chapman, Jong Chul Park, Alex Baras, George J. Netto, Ashley E. Ross, Trinity J. Bivalacqua, Noah M. Hahn
Purpose: To assess the clinical and pharmacodynamic activity of dovitinib in a treatment-resistant, molecularly enriched non–muscle-invasive urothelial carcinoma of the bladder (NMIUC) population.Experimental Design: A multi-site pilot phase II tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea34de834dad9113d9e0b8a39068aa3
https://doi.org/10.1158/1078-0432.c.6525227
https://doi.org/10.1158/1078-0432.c.6525227
Autor:
Daniel M. Geynisman, Richard E. Greenberg, Elizabeth R. Plimack, Gregory J. Tsongalis, Torrey Gallagher, Francine B. De Abreu, Scott A. Turner, Angela Reed, Rhoda L. Loman, Marietta L. Moore, Costantine Albany, Ziyue Liu, Timothy Breen, George E. Sandusky, Kyle McElyea, David R. Jones, Liang Cheng, Thomas A. Gardner, Richard S. Foster, Richard Bihrle, Michael O. Koch, Timothy A. Masterson, Carolyn Chapman, Jong Chul Park, Alex Baras, George J. Netto, Ashley E. Ross, Trinity J. Bivalacqua, Noah M. Hahn
Supplementary Table S3: Baseline Tumor pFGFR3 IHC Intensity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0da8c4662414b4762c610f7c5040e3b
https://doi.org/10.1158/1078-0432.22462832
https://doi.org/10.1158/1078-0432.22462832
Autor:
Daniel M. Geynisman, Richard E. Greenberg, Elizabeth R. Plimack, Gregory J. Tsongalis, Torrey Gallagher, Francine B. De Abreu, Scott A. Turner, Angela Reed, Rhoda L. Loman, Marietta L. Moore, Costantine Albany, Ziyue Liu, Timothy Breen, George E. Sandusky, Kyle McElyea, David R. Jones, Liang Cheng, Thomas A. Gardner, Richard S. Foster, Richard Bihrle, Michael O. Koch, Timothy A. Masterson, Carolyn Chapman, Jong Chul Park, Alex Baras, George J. Netto, Ashley E. Ross, Trinity J. Bivalacqua, Noah M. Hahn
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1738c5e2e605635531ae21305681e5ea
https://doi.org/10.1158/1078-0432.22462841.v1
https://doi.org/10.1158/1078-0432.22462841.v1
Autor:
Yunlong Liu, Maria B. Padua, Harikrishna Nakshatri, Susan M. Perkins, Sandra Althouse, Max Jacobsen, Sheng Liu, Jun Wan, Mayuri S. Prasad, George E. Sandusky, Yangyang Hao, Manjushree Anjanappa, Poornima Bhat-Nakshatri, Xi Rao, Kyle McElyea
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 20, Iss 1, Pp 1-18 (2018)
Breast Cancer Research, Vol 20, Iss 1, Pp 1-18 (2018)
Background The majority of estrogen receptor-positive (ERα+) breast cancers respond to endocrine therapies. However, resistance to endocrine therapies is common in 30% of cases, which may be due to altered ERα signaling and/or enhanced plasticity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c90cb3fa21dadbc8cbecdf575b5ca2
https://doi.org/10.1186/s13058-018-0963-5
https://doi.org/10.1186/s13058-018-0963-5
Autor:
Rasika Mundade, Lakshmi Prabhu, George E. Sandusky, Kyle McElyea, Tao Lu, Yunlong Liu, Han Wei, Constance J. Temm, Matthew Martin, Antja Voy Hartley, Benlian Wang
Publikováno v:
Oncotarget
Y-box binding protein 1 [YBX1] is a multifunctional protein known to facilitate many of the hallmarks of cancer. Elevated levels of YBX1 protein are highly correlated with cancer progression, making it an excellent marker in cancer. The connection be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a73dd6461587f8b3afc7ad46193cdc
https://doi.org/10.18632/oncotarget.5120
https://doi.org/10.18632/oncotarget.5120
Autor:
George E. Sandusky, Peter A. Crooks, Harikrishna Nakshatri, Max Jacobson, Courtney Finnearty, Ruizhong Wang, Mayuri S. Prasad, Narsimha Reddy Penthala, Poornima Bhat-Nakshatri, Kyle McElyea, Jianguo Liu, Manjushree Anjanappa, Teresa A. Zimmers, Victoria Sefcsik, Maria B. Padua, Rachael Redmond
Breast cancer progression is associated with systemic effects, including functional limitations and sarcopenia without the appearance of overt cachexia. Autocrine/paracrine actions of cytokines/chemokines produced by cancer cells mediate cancer progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b8c2def2c2647f6baa597d5dae2fc9
https://europepmc.org/articles/PMC5716864/
https://europepmc.org/articles/PMC5716864/